Patent Ductus Arteriosus Ligation Procedure in a 5 Year Old Girl

##plugins.themes.academic_pro.article.sidebar##

Published Apr 17, 2021
Download
PDF Download
Statistic

Downloads

Download data is not yet available.
Vol. 9 No. 2 (2021): April: Science Midwifery

##plugins.themes.academic_pro.article.main##

Riris Juita Julianty
Universitas Andalas
Didik Haryanto
Universitas Andalas

Abstract

Patent Ductus Arteriosus (PDA) is a congenital heart defect in which the closure of the ductus arteriosus is delayed after 72 hours. The incidence is frequent in the neonatal period and increases with the life expectancy of preterm infants. The clinical symptoms of PDA vary from asymptomatic to clinical heart failure, so PDA is often detected incidentally by echocardiogram. Reported a case of a 5 year old girl who has been known to suffer from PDA from echocardiography examination with a diameter of 3mm PDA. The patient has no complaints other than a continuous sound of heart sounds. Chest X-ray was examined with cardiomegaly results. The patient was treated with surgical ligation. The patient's condition after surgery is stable and there are no complaints.

##plugins.themes.academic_pro.article.details##

How to Cite
Julianty, R. J. and Didik Haryanto (2021) “Patent Ductus Arteriosus Ligation Procedure in a 5 Year Old Girl”, Science Midwifery, 9(2), pp. 366-371. Available at: https://midwifery.iocspublisher.org/index.php/midwifery/article/view/114 (Accessed: 12November2025).

References

[1] Jonathan W. Treatment of PDA. Seminars in Neonatology. 2003; 8 : 425-32
[2] DeSantis ERH, Clyman RI. Patent duktus arteriosus: pathophysiology and management. Jour of Perina. 2006; 26: 14–18
[3] Schneider DJ, Moore JW. Patent duktus arteriosus. Circ ahajournals. 2006;114:1873- 82
[4] Jhaveri N, Moon-Grady A, Clyman RI. Early surgical ligation versus a conservative approach for management of patent duktus arteriosus that fails to close after indomethacin treatment. Jpeds. Sept 2010; 157: 381-87
[5] Nora JJ. Multifactorial inheritance hypothesis for the etiology of congenital heart diseases: the genetic-environmental interaction. Circ ahajournals. 1968;38:604–17
[6] Gibson S, Lewis K. Congenital heart disease following maternal rubella during pregnancy. Am J Dis Child. 1952;83:117–19
[7] Tomita H, Fuse S, Hatakeyama K, Chiba S. Epinephrine-induced constriction of the persistent duktus arteriosus and its relation to distensibility. Jpn Circ J. 1998;62:913–14
[8] Kwinta P, Rudzinski A, Kruczek P, Kordon Z, Pietrzyk J. Can early echocardiographic findings predict patent duktus arteriosus. Neonatology 2009;95:141-48
[9] Becker TE, Ensing GJ, Darragh RK, Caldwell RL. Doppler derivation of complete pulmonary artery pressure curves in patent duktus arteriosus. Am J Cardiol. 1996;78:1066–69
[10] Hammerman C, Kaplan M. Comparative tolerability of pharmacological treatments for patent duktus arteriosus. Drug safety. 2001;24:537-51
[11] Clyman RI. Recommendations for the postnatal use of indometasin: an analysis of four separate treatment strategies. J Pediatr.1996; 128: 601-07
[12] Park MK. Pediatric Cardiology for Practitioner, fifth edition. Philadelphia; Elsevier; 2008
[13] UKK Kardiologi. Penanganan penyakit jantung bawaan pada anak. Jakarta; 2005
[14] Yamaki S, Ishidoya T, Osuga T, Arai S. Progressive pulmonary vaskular disease after surgery in a case of patent duktus arteriosus with pulmonary hypertension. Tohoku J Exp Med. 1983;140:279–88
[15] Hawkins JA, Minich LL, Tani LY, Sturtevant JE, Orsmond GS, McGough EC. Cost and efficacy of surgical ligation versus transcatheter coil occlusion of patent ductus arteriosus. Th jour Thor Card Surg. 1996;112(6):1634-39